{"id":"W2787816336","doi":"10.1200/jco.2017.35.15_suppl.tps5603","title":"ARIEL4: An international, multicenter randomized phase 3 study of the PARP inhibitor rucaparib vs chemotherapy in germline or somatic <i>BRCA1-</i> or <i>BRCA2-</i>mutated, relapsed, high-grade ovarian carcinoma.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; PARP inhibitor; BRCA mutation; Oncology; Germline mutation; Chemotherapy; Olaparib; Ovarian cancer; Regimen; Cancer; Mutation; Poly ADP ribose polymerase; Biology; Genetics; Polymerase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003706946,0.002471848,0.002293702,0.0005679828,0.0004944262,0.001557449,0.00184066,0.002544806,0.01423838],"category_scores_gemma":[0.003129689,0.0007938569,0.002935918,0.0005639161,0.001017358,0.001529351,0.0006651902,0.005877145,0.002389976],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001355073,"about_ca_system_score_gemma":0.001832311,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001451799,"about_ca_topic_score_gemma":0.003707956,"domain_scores_codex":[0.9989222,0.0006481289,0.00004340152,0.000147628,0.00007993366,0.0001587637],"domain_scores_gemma":[0.9983146,0.000452268,0.0004748988,0.0001158069,0.0001059446,0.0005365292],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9570707,0.01389229,0.0007214695,0.0007052481,0.001314894,0.00004902019,0.00005281903,0.0005957939,0.002226348,0.0002482731,0.003279269,0.01984377],"study_design_scores_gemma":[0.9414888,0.05460889,0.000916274,0.00004180509,0.0004927292,0.00004275743,0.00002112131,0.000495145,0.0002890948,0.0002299846,0.001358178,0.0000152245],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9327886,0.01337915,0.00297868,0.004531201,0.002487487,0.02265562,0.00898647,0.0008095095,0.01138337],"genre_scores_gemma":[0.9337061,0.005749275,0.006482171,0.007396157,0.001105814,0.02590213,0.00633838,0.0001625735,0.01315747],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01423838,"threshold_uncertainty_score":0.04763216,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1238525906724023,"score_gpt":0.4860857614442218,"score_spread":0.3622331707718195,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}